Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C25H35NO9 |
| Molecular Weight | 493.5467 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 11 / 11 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)[C@@]1(O)[C@@H](OC(=O)C2=CC=CN2)[C@@]3(O)[C@@]4(C)C[C@]5(O)O[C@@]6([C@H](O)[C@@H](C)CC[C@]46O)[C@@]3(O)[C@]15C
InChI
InChIKey=JJSYXNQGLHBRRK-YSOSZROBSA-N
InChI=1S/C25H35NO9/c1-12(2)22(31)17(34-16(28)14-7-6-10-26-14)23(32)18(4)11-21(30)19(22,5)25(23,33)24(35-21)15(27)13(3)8-9-20(18,24)29/h6-7,10,12-13,15,17,26-27,29-33H,8-9,11H2,1-5H3/t13-,15+,17+,18-,19-,20-,21-,22+,23+,24+,25+/m0/s1
| Molecular Formula | C25H35NO9 |
| Molecular Weight | 493.5467 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 11 / 11 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Ryanodine (or ryania), a natural product found in members of the genusRyania and was previously used in insecticides. Its properties and biological actions have permitted the identification and molecular characterization of a family of intracellular Ca2+ release channels, now commonly termed the ryanodine receptors. Ryanodine binds with high affinity to the ryanodine receptors to modulate intracellular Ca2+ release, depending on the concentration used
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: P21817 Gene ID: 6261.0 Gene Symbol: RYR1 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/3985981 |
11.3 nM [Kd] | ||
Target ID: Q92736 Gene ID: 6262.0 Gene Symbol: RYR2 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/3985981 |
|||
Target ID: Q15413 Gene ID: 6263.0 Gene Symbol: RYR3 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/9718083 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
PubMed
| Title | Date | PubMed |
|---|---|---|
| Structure-activity relationship of selected meta- and para-hydroxylated non-dioxin like polychlorinated biphenyls: from single RyR1 channels to muscle dysfunction. | 2013-12 |
|
| The calcium signaling pathway regulates leydig cell steroidogenesis through a transcriptional cascade involving the nuclear receptor NR4A1 and the steroidogenic acute regulatory protein. | 2013-01 |
|
| Para- and ortho-substitutions are key determinants of polybrominated diphenyl ether activity toward ryanodine receptors and neurotoxicity. | 2011-04 |
|
| Ryanodine receptor-2 upregulation and nicotine-mediated plasticity. | 2011-01-05 |
|
| Lysosome-dependent Ca(2+) release response to Fas activation in coronary arterial myocytes through NAADP: evidence from CD38 gene knockouts. | 2010-05 |
|
| Enantiomeric specificity of (-)-2,2',3,3',6,6'-hexachlorobiphenyl toward ryanodine receptor types 1 and 2. | 2009-01 |
|
| In vitro biologic activities of the antimicrobials triclocarban, its analogs, and triclosan in bioassay screens: receptor-based bioassay screens. | 2008-09 |
|
| FK506 binding protein 12/12.6 depletion increases endothelial nitric oxide synthase threonine 495 phosphorylation and blood pressure. | 2007-03 |
|
| Doxorubicin-induced reactive oxygen species generation and intracellular Ca2+ increase are reciprocally modulated in rat cardiomyocytes. | 2006-10-31 |
|
| Calcium transients regulate titin organization during myofibrillogenesis. | 2005-03 |
|
| Doxorubicin cardiac dysfunction: effects on calcium regulatory proteins, sarcoplasmic reticulum, and triiodothyronine. | 2005 |
|
| Endothelin B receptor Ca2+ signaling in shark vascular smooth muscle: participation of inositol trisphosphate and ryanodine receptors. | 2004-09 |
|
| Calcium transients regulate patterned actin assembly during myofibrillogenesis. | 2004-02 |
|
| Dantrolene inhibition of ryanodine receptor Ca2+ release channels. Molecular mechanism and isoform selectivity. | 2001-04-27 |
|
| Effect of sulphur mustard on the expression of urokinase in cultured 3T3 fibroblasts. | 1997 |
|
| The effect of flunarizine and ryanodine on acquired torsades de pointes arrhythmias in the intact canine heart. | 1995-03 |
|
| Effect of ryanodine on ventricular fibrillation induced by myocardial ischaemia. | 1993-12 |
|
| Sodium-pump injury and arrhythmogenic transient depolarizations in catecholamine-induced cardiac hypertrophy. | 1992-01-21 |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1851961
Kinetic and equilibrium measurements of [3H]ryanodine (ryania) binding to the Ca2+ release channel of rabbit skeletal and rat cardiac sarcoplasmic reticulum (SR) are examined to ascertain the nature of cooperative interactions among high and low affinity binding sites and to quantitate their distribution. Equilibrium studies reveal affinities of 1-4 nM for the highest affinity binding site and of 30-50 nM, 500-800 nM, and 2-4 microM for the lower affinity sites in both preparations, with Hill coefficients of significantly less than 1, and initial rates of association and dissociation increase with increasing concentrations of ryanodine.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:52:31 GMT 2025
by
admin
on
Mon Mar 31 21:52:31 GMT 2025
|
| Record UNII |
37H6ATE4SA
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
EPA PESTICIDE CODE |
71502
Created by
admin on Mon Mar 31 21:52:31 GMT 2025 , Edited by admin on Mon Mar 31 21:52:31 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
8047-13-0
Created by
admin on Mon Mar 31 21:52:31 GMT 2025 , Edited by admin on Mon Mar 31 21:52:31 GMT 2025
|
SUPERSEDED | |||
|
15662-33-6
Created by
admin on Mon Mar 31 21:52:31 GMT 2025 , Edited by admin on Mon Mar 31 21:52:31 GMT 2025
|
PRIMARY | |||
|
m9712
Created by
admin on Mon Mar 31 21:52:31 GMT 2025 , Edited by admin on Mon Mar 31 21:52:31 GMT 2025
|
PRIMARY | Merck Index | ||
|
Ryanodine
Created by
admin on Mon Mar 31 21:52:31 GMT 2025 , Edited by admin on Mon Mar 31 21:52:31 GMT 2025
|
PRIMARY | |||
|
114572
Created by
admin on Mon Mar 31 21:52:31 GMT 2025 , Edited by admin on Mon Mar 31 21:52:31 GMT 2025
|
PRIMARY | |||
|
441753
Created by
admin on Mon Mar 31 21:52:31 GMT 2025 , Edited by admin on Mon Mar 31 21:52:31 GMT 2025
|
PRIMARY | |||
|
ryania
Created by
admin on Mon Mar 31 21:52:31 GMT 2025 , Edited by admin on Mon Mar 31 21:52:31 GMT 2025
|
PRIMARY | |||
|
37H6ATE4SA
Created by
admin on Mon Mar 31 21:52:31 GMT 2025 , Edited by admin on Mon Mar 31 21:52:31 GMT 2025
|
PRIMARY | |||
|
239-732-2
Created by
admin on Mon Mar 31 21:52:31 GMT 2025 , Edited by admin on Mon Mar 31 21:52:31 GMT 2025
|
PRIMARY | |||
|
DTXSID0032574
Created by
admin on Mon Mar 31 21:52:31 GMT 2025 , Edited by admin on Mon Mar 31 21:52:31 GMT 2025
|
PRIMARY | |||
|
8925
Created by
admin on Mon Mar 31 21:52:31 GMT 2025 , Edited by admin on Mon Mar 31 21:52:31 GMT 2025
|
PRIMARY |